Intracellular CD154 Expression Reflects Antigen-specific ![]() |
Han, Young-Woo
(Department of Microbiology, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University)
Aleyas, Abi G. (Department of Microbiology, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University) George, Junu A. (Department of Microbiology, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University) Yoon, Hyun-A (Department of Microbiology, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University) Lee, John-Hwa (Department of Microbiology, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University) Kim, Byung-Sam (Immunomodulation Research Center, University of Ulsan) Eo, Seong-Kug (Department of Microbiology, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University) |
1 | Beadling, C. and M. K. Slifka. 2006. Quantifying viable virus-specific T cells without a priori knowledge of fine epitope specificity. Nat. Med. 12: 1208-1212 DOI ScienceOn |
2 | Behrens, G., M. Li, C. M. Smith, G. T. Belz, J. Mintern, F. R. Carbone, and W. R. Heath. 2004. Helper T cells, dendritic cells and CTL immunity. Immunol. Cell Biol. 82: 84-90 DOI ScienceOn |
3 | Betts, M. R., J. P. Casazza, B. A. Patterson, S. Waldrop, W. Trigona, T. M. Fu, F. Kern, L. J. Picker, and R. A. Koup. 2000. Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype. J. Virol. 74: 9144-9151 DOI ScienceOn |
4 | Fadel, S. A., L. G. Cowell, S. Cao, D. A. Ozaki, T. B. Kepler, D. A. Steeber, and M. Sarzotti. 2006. Neonate-primed CD8+ memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection. Int. Immunol. 18: 249-257 DOI ScienceOn |
5 | Falco, D. A., R. R. Nepomuceno, S. M. Krams, P. P. Lee, M. M. Davis, O. Salvatierra, S. R. Alexander, C. O. Esquivel, K. L. Cox, L. R. Frankel, and O. M. Martinez. 2002. Identification of Epstein-Barr virus-specific CD8+ T lymphocytes in the circulation of pediatric transplant recipients. Transplantation 74: 501-510 DOI ScienceOn |
6 | Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 8: 177-187 DOI ScienceOn |
7 | Roy, M., T. Waldschmidt, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J. Immunol. 151: 2497-2510 |
8 | Salem, M. L., A. N. Kadima, D. J. Cole, and W. E. Gillanders. 2005. Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: Evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity. J. Immunother. 28: 220-228 DOI ScienceOn |
9 | Trapani, J. A. and M. J. Smyth. 2002. Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2: 735-747 DOI ScienceOn |
10 | Huang, X. L., Z. Fan, C. Kalinyak, J. W. Mellors, and C. R. Rinaldo Jr. 2000. CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects. Clin. Diagn. Lab. Immunol. 7: 279-287 |
11 | Sun, J. C. and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342 DOI ScienceOn |
12 | Koo, J. H., W. J. Chae, J. M. Choi, H. W. Nam, T. Morio, Y. S. Kim, Y. S. Jang, K. Y. Choi, J. J. Yang, and S. K. Lee. 2006. Proteomic analysis of resting and activated human CD8+ T cells. J. Microbiol. Biotechnol. 16: 911-920 과학기술학회마을 |
13 | Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, and R. A. Koup. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78 DOI |
14 | Kim, H. P., M. R. Jin, I. Y. Kim, B. Y. Ahn, and S. M. Kang. 1999. Analysis of the major histocompatibility complex class I antigen presentation machinery in human lung cancer. J. Microbiol. Biotechnol. 9: 346-351 |
15 | Trautmann, L., L. Janbazian, N. Chomont, E. A. Said, S. Gimmig, B. Bessette, M. R. Boulassel, E. Delwart, H. Sepulveda, R. S. Balderas, J. P. Routy, E. K. Haddad, and R. P. Sekaly. 2006. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202 DOI ScienceOn |
16 | Douek, D. C., M. R. Betts, J. M. Brenchley, B. J. Hill, D. R. Ambrozak, K. L. Ngai, N. J. Karandikar, J. P. Casazza, and R. A. Koup. 2002. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J. Immunol. 168: 3099-3104 DOI |
17 | Sonn, C. H., H. R. Yoon, I. O. Seong, M. R. Chang, Y. C. Kim, H. C. Kang, S. C. Suh, and Y. S. Kim. 2006. MethA fibrosarcoma cells expressing membrane-bound forms of IL- 2 enhance antitumor immunity. J. Microbiol. Biotechnol. 16: 1919-1927 과학기술학회마을 |
18 | van Kooten, C. and J. Banchereau. 2000. CD40-CD40 ligand. J. Leukoc. Biol. 67: 2-17 DOI |
19 | Chattopadhyay, P. K., J. Yu, and M. Roederer. 2005. Alivecell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat. Med. 11: 1113-1137 DOI ScienceOn |
20 | Misumi, Y., Y. Misumi, K. Miki, A. Takatsuki, G. Tamura, and Y. Ikehara. 1986. Novel blockade by Brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J. Biol. Chem. 261: 11398-11403 |
21 | Kang, K. Y., C. H. Choi, J. Y. Oh, H. Kim, G. R. Kweon, and J. C. Lee. 2005. Chloramphenicol arrests transition of cell cycle and induces apoptotic cell death in myelogenous leukemia cells. J. Microbiol. Biotechnol. 15: 913-918 |
22 | Yellin, M. J., K. Sippel, G. Inghirami, L. R. Covey, J. J. Lee, J. Sinning, E. A. Clark, L. Chess, and S. Lederman. 1994. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. J. Immunol. 152: 598-608 |
23 | Kern, F., I. P. Surel, C. Brock, B. Freistedt, H. Radtke, A. Scheffold, R. Blasczyk, P. Reinke, J. Schneider-Mergener, A. Radbruch, P. Walden, and H. D. Volk. 1998. T-cell epitope mapping by flow cytometry. Nat. Med. 4: 975-978 DOI ScienceOn |
24 | Sad, S., L. Krishnan, R. C. Bleackley, D. Kagi, H. Hengartner, and T. R. Mosmann. 1997. Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity. Eur. J. Immunol. 27: 914-922 DOI ScienceOn |
25 | Graf, D., U. Korthauer, H. W. Mages, G. Senger, and R. A. Kroczek. 1992. Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol. 22: 3191-3194 DOI ScienceOn |
26 | Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96 DOI ScienceOn |
27 | Walker, E. B. and M. L. Disis. 2003. Monitoring immune responses in cancer patients receiving tumor vaccines. Int. Rev. Immunol. 22: 283-319 DOI ScienceOn |
28 | Frentsch, M., O. Arbach, D. Kirchhoff, B. Moewes, M. Worm, M. Rothe, A. Scheffold, and A. Thiel. 2005. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat. Med. 11: 1118-1124 DOI ScienceOn |
29 | Bartholomae, W. C., F. H. Rininsland, J. C. Eisenberg, B. O. Boehm, P. V. Lehmann, and M. Tary-Lehmann. 2004. T cell immunity induced by live, necrotic, and apoptotic tumor cells. J. Immunol. 173: 1012-1022 DOI |
30 | Clay, T. M., A. C. Hobeika, P. J. Mosca, H. K. Lyerly, and M. A. Morse. 2001. Assays for monitoring cellular immune responses to active immunotherapy of cancer. Clin. Cancer Res. 7: 1127-1135 |
31 | Yim, S. B. and Y. H. Chung. 2004. Construction and production of concatameric human TNF receptor-immunoglobulin fusion proteins. J. Microbiol. Biotechnol. 14: 81-89 |
32 | Chang, J., J. H. Cho, S. W. Lee, S. Y. Choi, S. J. Ha, and Y. C. Sung. 2004. IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells. J. Immunol. 172: 2818-2826 DOI |
33 | Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687 DOI ScienceOn |
34 | Scott-Algara, D., F. Buseyne, F. Porrot, B. Corre, N. Bellal, C. Rouzioux, S. Blanche, and Y. Riviere. 2005. Not all tetramer binding CD8+ T cells can produce cytokines and chemokines involved in the effector functions of virusspecific CD8+ T lymphocytes in HIV-1 infected children. J. Clin. Immunol. 25: 57-67 DOI ScienceOn |
35 | Whiteside, T. L. and J. A. Hank. 2002. Monitoring of immunologic therapies, pp. 1108-1117. In R. G. H. R. N. Rose, and B. Detrick (eds.), Manual of Clinical Laboratory Immunology, 6th Ed. ASM, Washington, DC |
36 | Appay, V., D. F. Nixon, S. M. Donahoe, G. M. Gillespie, T. Dong, A. King, G. S. Ogg, H. M. Spiegel, C. Conlon, C. A. Spina, D. V. Havlir, D. D. Richman, A. Waters, P. Easterbrook, A. J. McMichael, and S. L. Rowland-Jones. 2000. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192: 63-75 DOI ScienceOn |
37 | Armitage, R. J., W. C. Fanslow, L. Strockbine, T. A. Sato, K. N. Clifford, B. M. Macduff, D. M. Anderson, S. D. Gimpel, T. Davis-Smith, C. R. Maliszewski, et al. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature 357: 80-82 DOI ScienceOn |
38 | Kuzushima, K., N. Hayashi, A. Kudoh, Y. Akatsuka, K. Tsujimura, Y. Morishima, and T. Tsurumi. 2003. Tetramerassisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virusspecific CD8+ T cells. Blood 101: 1460-1468 DOI ScienceOn |
39 | Hermann, P., C. Van-Kooten, C. Gaillard, J. Banchereau, and D. Blanchard. 1995. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation. Eur. J. Immunol. 25: 2972-2977 DOI ScienceOn |
40 | Shedlock, D. J. and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339 DOI |
![]() |